Weiss Multi-Strategy Advisers’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,500
Closed -$2.49M 719
2023
Q3
$2.49M Sell
12,500
-6,926
-36% -$1.64M 0.06% 349
2023
Q2
$5.54M Buy
19,426
+13,039
+204% +$3.62M 0.11% 261
2023
Q1
$1.39M Buy
6,387
+1,987
+45% +$387K 0.03% 476
2022
Q4
$905K Buy
4,400
+2,700
+159% +$683K 0.03% 469
2022
Q3
$473K Buy
1,700
+400
+31% +$102K 0.01% 557
2022
Q2
$249K Buy
+1,300
New +$229K 0.01% 601
2020
Q1
Sell
-5,000
Closed -$220K 657
2019
Q4
$220K Buy
+5,000
New +$185K ﹤0.01% 571

Other funds holding SWAV

Weiss Multi-Strategy Advisers's SWAV Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 12,500 shares — an estimated $2.49M sold.

Weiss Multi-Strategy Advisers first reported a position in SWAV in Q4 2019 and held it in 7 quarters. The position peaked at $5.54M in Q2 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 12,500 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $2.49M.
  • Weiss Multi-Strategy Advisers first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Shockwave Medical, Inc. Common Stock position peaked at $5.54M in Q2 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.